2011
DOI: 10.1002/psb.841
|View full text |Cite
|
Sign up to set email alerts
|

Digoxin doses over 125μg daily in vulnerable patient groups

Abstract: In this series we present a number of prescribing safety indicators developed as part of an RCGP project.1 The evidence base behind each of the indicators is given along with information to illustrate their clinical significance. We provide a ‘real‐life’ audit based on the indicator to show how practices could begin to analyse their own prescribing data. Copyright © 2011 Wiley Interface Ltd

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2014
2014
2014
2014

Publication Types

Select...
1

Relationship

1
0

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 1 publication
0
1
0
Order By: Relevance
“…An intervention study will also be conducted to determine whether these indicators, as part of a larger patient safety toolkit, can be used to improve patient safety. The indicators might equally well be used for practice learning, revalidation or audit purposes (see article series in Prescriber [31][32][33][34][35][36] for examples of how this can be accomplished).…”
Section: Implications For Research and Practicementioning
confidence: 99%
“…An intervention study will also be conducted to determine whether these indicators, as part of a larger patient safety toolkit, can be used to improve patient safety. The indicators might equally well be used for practice learning, revalidation or audit purposes (see article series in Prescriber [31][32][33][34][35][36] for examples of how this can be accomplished).…”
Section: Implications For Research and Practicementioning
confidence: 99%